Search Results - "Heublein, Bernd"

Refine Results
  1. 1
  2. 2
  3. 3

    Mechanism of luminal narrowing in cardiac allograft vasculopathy: Inadequate vascular remodeling rather than intimal hyperplasia is the major predictor of coronary artery stenosis by Pethig, Klaus, Heublein, Bernd, Wahlers, Thorsten, Haverich, Axel

    Published in The American heart journal (01-04-1998)
    “…Background: Despite increasing knowledge about degree and distribution pattern of intimal hyperplasia in cardiac allograft vasculopathy, coronary artery…”
    Get full text
    Journal Article
  4. 4

    Volumetric remodeling of the proximal left coronary artery by Pethig, Klaus, Heublein, Bernd, Meliss, Rolf R, Haverich, Axel

    “…OBJECTIVES The aim of this study was to characterize progression of cardiac allograft vasculopathy (CAV) with special respect to coronary artery geometry…”
    Get full text
    Journal Article
  5. 5

    Preliminary Results after Application of Absorbable Metal Stents in Patients with Critical Limb Ischemia by Peeters, Patrick, Bosiers, Marc, Verbist, Juergen, Deloose, Koen, Heublein, Bernd

    Published in Journal of endovascular therapy (01-02-2005)
    “…Purpose: To report the preliminary 3-month follow-up of a recently developed absorbable metal stent (AMS) for treatment of infrapopliteal lesions in patients…”
    Get full text
    Journal Article
  6. 6

    Coronary-Artery Stenting Compared with Balloon Angioplasty for Restenosis after Initial Balloon Angioplasty by Erbel, Raimund, Haude, Michael, Höpp, Hans W, Franzen, Damian, Rupprecht, Hans Jürgen, Heublein, Bernd, Fischer, Klaus, de Jaegere, Peter, Serruys, Patrick, Rutsch, Wolfgang, Probst, Peter

    Published in The New England journal of medicine (03-12-1998)
    “…An important limitation of coronary balloon angioplasty is restenosis, which occurs in 30 to 50 percent of patients. 1 – 5 Independent risk factors for…”
    Get full text
    Journal Article
  7. 7

    Mycophenolate mofetil for secondary prevention of cardiac allograft vasculopathy: influence on inflammation and progression of intimal hyperplasia by Pethig, Klaus, Heublein, Bernd, Wahlers, Thorsten, Dannenberg, Olliver, Oppelt, Petra, Haverich, Axel

    “…Cardiac allograft vasculopathy (CAV) remains the single most important complication impairing long-term survival after heart transplantation (HTx). Intimal…”
    Get more information
    Journal Article
  8. 8

    Systemic inflammatory response in cardiac allograft vasculopathy: high-sensitive C-reactive protein is associated with progressive luminal obstruction by PETHIG, Klaus, HEUBLEIN, Bernd, KUTSCHKA, Ingo, HAVERICH, Axel

    Published in Circulation (New York, N.Y.) (07-11-2000)
    “…Response to immunologic and nonimmunologic injury has been reported to initiate the development of cardiac allograft vasculopathy (CAVD). Although…”
    Get full text
    Journal Article
  9. 9

    Preclinical evaluation of inducible nitric oxide synthase lipoplex gene therapy for inhibition of stent-induced vascular neointimal lesion formation by Muhs, Andreas, Heublein, Bernd, Schletter, Jens, Herrmann, Andreas, Rüdiger, Manfred, Sturm, Matthias, Grust, Andreas, Malms, Jochen, Schrader, Jürgen, von der Leyen, Heiko E

    Published in Human gene therapy (01-03-2003)
    “…Several reports have established the concept of nitric oxide synthase (NOS) gene transfer for inhibiting smooth muscle cell (SMC) proliferation after vascular…”
    Get more information
    Journal Article
  10. 10

    Volumetric remodeling of the proximal left coronary artery : Early versus late after heart transplantation by PETHIG, K, HEUBLEIN, B, MELISS, R. R, HAVERICH, A

    “…The aim of this study was to characterize progression of cardiac allograft vasculopathy (CAV) with special respect to coronary artery geometry. As previously…”
    Get full text
    Journal Article
  11. 11

    Randomized comparison of balloon angioplasty versus silicon Carbon-Coated stent implantation for de novo lesions in small coronary arteries by Hanekamp, Clara, Koolen, Jacques, Bonnier, Hans, Oldroyd, Keith, de Boer, Menko-Jan, Heublein, Bernd, Visser, Cees

    Published in The American journal of cardiology (15-05-2004)
    “…The objectives of this study were to compare the short- and long-term clinical and angiographic outcomes of conventional balloon angioplasty versus elective…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Systemic Inflammatory Response in Cardiac Allograft Vasculopathy: High-Sensitive C-Reactive Protein Is Associated With Progressive Luminal Obstruction by Pethig, Klaus, Heublein, Bernd, Kutschka, Ingo, Haverich, Axel

    Published in Circulation (New York, N.Y.) (07-11-2000)
    “…Background —Response to immunologic and nonimmunologic injury has been reported to initiate the development of cardiac allograft vasculopathy (CAVD). Although…”
    Get full text
    Journal Article
  14. 14

    ACE-gene polymorphism is associated with the development of allograft vascular disease in heart transplant recipients by Pethig, K, Heublein, B, Hoffmann, A, Borlak, J, Wahlers, T, Haverich, A

    “…Cardiac allograft vascular disease is (CAVD) the most important cause of death following heart transplantation (HTX). Although in the past, researchers focused…”
    Get more information
    Journal Article
  15. 15

    Impact of vascular branching sites on focal progression of allograft vasculopathy in transplanted hearts by Pethig, Klaus, Kofidis, Theo, Heublein, Bernd, Westphal, Andrea, Haverich, Axel

    Published in Atherosclerosis (01-09-2001)
    “…Background: Cardiac allograft vascular disease (CAVD) represents one of the most accelerated progressing coronary syndromes in the human heart. A variety of…”
    Get full text
    Journal Article
  16. 16

    Coronary artery stenting in cardiac allograft vascular disease by Heublein, Bernd, Pethig, Klaus, Maaß, Christian, Wahlers, Thorsten, Haverich, Axel, Cardiac Allograft Vasculopathy

    Published in The American heart journal (01-11-1997)
    “…Cardiac allograft vascular disease is characterized by diffuse and multifocal heterogeneous myointimal hyperplasia with or without vascular remodeling…”
    Get full text
    Journal Article
  17. 17

    Cardiac allograft vascular disease after orthotopic heart transplantation : Methylenetetrahydrofolate reductase gene polymorphism C677T does not account for rapidly progressive forms by PETHIC, K, HOFFMANN, A, HEUBLEIN, B, TIMKE, A, GROSS, G, HAVERICH, A

    Published in Transplantation (15-02-2000)
    “…Recently, homocysteine (HCY) levels have been suggested to be a risk factor in cardiac allograft vascular disease (CAVD). As plasma levels are partially under…”
    Get full text
    Conference Proceeding Journal Article
  18. 18

    Impact of Plaque Burden on Compensatory Enlargement of Coronary Arteries in Cardiac Allograft Vasculopathy by Pethig, Klaus, Heublein, Bernd, Wahlers, Thorsten

    Published in The American journal of cardiology (01-01-1997)
    “…Using intravascular ultrasound, Pethig et al demonstrated plaque-induced compensatory enlargement of coronary arteries in cardiac allograft vasculopathy…”
    Get full text
    Journal Article
  19. 19

    Polymerized degradable hyaluronan--a platform for stent coating with inherent inhibitory effects on neointimal formation in a porcine coronary model by Heublein, B, Evagorou, E G, Rohde, R, Ohse, S, Meliss, R R, Barlach, S, Haverich, A

    Published in International journal of artificial organs (01-12-2002)
    “…Biodegradable hyaluronan (hyaluronic acid, HA) made insoluble by self-cross-linking in the presence of N-(3-dimethylaminopropyl)-N'-ethyl carbodiimide (EDC)…”
    Get full text
    Journal Article
  20. 20